JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266494

Human GTF3C6 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

GTF3C6 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 1.

View Alternative Names

C6ORF51, General transcription factor 3C polypeptide 6, General transcription factor IIIC polypeptide 6 alpha, General transcription factor IIIC, polypeptide 6, alpha 35kDa, TF3C6_HUMAN, TFIIIC 35 kDa subunit, TFIIIC35, Transcription factor IIIC 35 kDa subunit, Transcription factor IIIC 35kDa, Transcription factor IIIC polypeptide 6, Transcription factor IIIC subunit 6, bA397G5.3

1 Images
Sanger Sequencing - Human GTF3C6 knockout HEK-293T cell line (AB266494)
  • Sanger seq

Unknown

Sanger Sequencing - Human GTF3C6 knockout HEK-293T cell line (AB266494)

Homozygous : 2 bp deletion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 1

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266494-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266494 Human GTF3C6 knockout HEK-293T cell line", "number":"AB266494-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266494-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266494 Human GTF3C6 knockout HEK-293T cell line", "number":"AB266494-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
GTF3C6
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GTF3C6 also known as Transcription Factor IIIC subunit 6 is a component of the transcription factor IIIC (TFIIIC) complex. It weighs approximately 78 kilodaltons and plays a mechanical role in the transcription process. GTF3C6 facilitates the assembly of the TFIIIC complex on DNA enabling the recruitment of RNA polymerase III. The protein is expressed in various tissues reflecting its role in basic cellular functions.
Biological function summary

The protein contributes to the transcription of small non-coding RNA genes such as 5S rRNA and tRNAs. GTF3C6 is a subunit of the TFIIIC complex and its function involves the recognition of specific promoter elements on DNA which is imperative for initiating transcription. By participating in the recognition and structuring of promoter regions GTF3C6 ensures proper transcription activation necessary for cell growth and metabolism.

Pathways

The engagement of GTF3C6 in RNA polymerase III transcription is significant. It operates within the RNA polymerase III transcription pathways interacting with TFIIIB and RNA polymerase III which are key components of the transcription machinery. GTF3C6 plays a role in the complex network of transcription regulation ensuring the timely transcription of essential RNAs that regulate protein synthesis and cell cycle progression.

Altered expression or dysfunction of GTF3C6 may associate with certain types of cancers. Given its role in transcription regulation deviations in GTF3C6 activity can disrupt normal cell proliferation processes. Association between GTF3C6 and other proteins in the RNA polymerase III pathway such as TFIIIB has shown relevance in studies of oncogenesis and potential cancer treatment avenues. Understanding these relationships can open doors to targeted therapies for diseases that involve dysregulation of transcription.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com